SCHEMBL171234

SCHEMBL171234

N#Cc1ccc(Cc2ccncc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.53
LOXL2 Q9Y4K0 2/20 0.52
CYP19A1 P11511 6/20 0.50
CYP2A6 P11509 1/20 0.50
SAE1 Q9UBE0 1/20 0.50
UBA2 Q9UBT2 1/20 0.50
CYP11B1 P15538 5/20 0.49
CYP11B2 P19099 5/20 0.49
CYP17A1 P05093 2/20 0.48
CYP3A4 P08684 2/20 0.48
GSK3A P49840 2/20 0.46
GSK3B P49841 2/20 0.46
POLB P06746 2/20 0.46
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
HPGD P15428 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1344068 0.86 LOXL2 (0.65) HRH3LOXL2CYP19A1CYP2A6SAE1
SCHEMBL13873567 0.81 CYP17A1 (0.65) HRH3LOXL2CYP19A1CYP11B1CYP11B2
SCHEMBL16848648 0.79 LOXL2 (0.58) HRH3LOXL2CYP19A1CYP2A6SAE1
SCHEMBL14155434 0.79 LOXL2 (0.58) HRH3LOXL2CYP19A1CYP2A6SAE1
SCHEMBL171226 0.79 HRH3 (0.56) HRH3CYP19A1CYP11B1CYP11B2CYP17A1
SCHEMBL1507736 0.79 CYP11B2 (0.56) HRH3CYP19A1CYP11B1CYP11B2KDM4E
Isonicotinonitrile SCHEMBL2015834 0.78 HDAC8 (0.52) LOXL2CYP19A1CYP2A6CYP11B1CYP11B2
Isonicotinonitrile SCHEMBL12264099 0.78
Isonicotinonitrile SCHEMBL151611 0.78
SCHEMBL721736 0.78 CYP17A1 (0.61) HRH3LOXL2CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426122-A1 Methylene urea derivative as RAF kinasse inhibitors Merck Patent GmbH (DE) 2012-03-07 EP disclosed
EP-0504574-B1 1,2,4-Oxadiazole derivatives having monoamine oxidase B enzyme-inhibitory activity and method for preparing same WAKAMOTO PHARMA CO LTD (JP) 1996-02-28 EP disclosed
US-5356916-A Treating Parkinson*s disease WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1994-10-18 US disclosed
EP-0504574-A1 1,2,4-Oxadiazole derivatives having monoamine oxidase B enzyme-inhibitory activity and method for preparing same Wakamoto Pharmaceutical Co., Ltd. (JP) 1992-09-23 EP disclosed